Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides

Immunology

Volumn 132, Issue 4, 2011, Pages 482-491

  Wang, Mingjun ^a   Tang, Sheila T ^b   Stryhn, Anette ^a   Justesen, Sune ^a   Larsen, Mette V ^b   Dziegiel, Morten H ^c   Lewinsohn, David M ^d   Buus, Søren ^a   Lund, Ole ^b   Claesson, Mogens H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Cytotoxic T lymphocyte epitope; HLA I; HLA II; Mycobacterium tuberculosis; Vaccine

Indexed keywords

BACTERIAL PROTEIN; BINDING PROTEIN; EPITOPE; GAMMA INTERFERON; HLA ANTIBODY; HLA DR ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 ANTIBODY; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MOTIF; T CELL DEPLETION;

ADULT; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79952498466     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03383.x     Document Type: Article

References (55)

1. LoBue P. Extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2009; 22:167-73.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.
3. Dietrich J, Lundberg CV, Andersen P. TB vaccine strategies - what is needed to solve a complex problem? Tuberculosis (Edinb) 2006; 86:163-8.
4. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96:29-35.
5. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
6. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
7. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med 2000; 192:347-58.
8. Moreira AL, Wang J, Tsenova-Berkova L, Hellmann W, Freedman VH, Kaplan G. Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route. Infect Immun 1997; 65:305-8.
9. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999; 162:5407-16.
10. + T cells. Infect Immun 1987; 55:2037-41.
11. Raupach B, Kaufmann SH. Immune responses to intracellular bacteria. Curr Opin Immunol 2001; 13:417-28.
12. + T cells in human tuberculosis. Proc Natl Acad Sci USA 2000; 97:12210-5.
13. + T lymphocytes against Mycobacterium tuberculosis. Arch Immunol Ther Exp (Warsz) 1999; 47:313-20.
14. + CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000; 165:353-63.
15. + cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect Immun 1997; 65:4525-30.
16. + T cells. Infect Immun 1999; 67:5223-30.
17. Stenger S. Cytolytic T cells in the immune response to Mycobacterium tuberculosis. Scand J Infect Dis 2001; 33:483-7.
18. Lund O, Nielsen M, Kesmir C et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 2004; 55:797-810.
19. Frieder M, Lewinsohn DM. T-cell epitope mapping in Mycobacterium tuberculosis using PepMixes created by Micro-Scale. Methods Mol Biol 2009; 524:369-82.
20. De Groot AS, Bosma A, Chinai N, Frost J, Jesdale BM, Gonzalez MA, Martin W, Saint-Aubin C. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 2001; 19:4385-95.
21. De Groot AS, Rappuoli R. Genome-derived vaccines. Expert Rev Vaccines 2004; 3:59-76.
22. Dockrell HM, Brahmbhatt S, Robertson BD et al. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents. Infect Immun 2000; 68:5846-55.
23. Hammond AS, Klein MR, Corrah T, Fox A, Jaye A, McAdam KP, Brookes RH. Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes. Clin Exp Immunol 2005; 140:109-16.
24. Martin W, Sbai H, De Groot AS. Bioinformatics tools for identifying class I-restricted epitopes. Methods 2003; 29:289-98.
25. McMurry JA, Kimball S, Lee JH et al. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. Curr Mol Med 2007; 7:351-68.
26. Tang ST, Wang M, Lamberth K, Harndahl M, Dziegiel MH, Claesson MH, Buus S, Lund O. MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30years after vaccination. Arch Virol 2008; 153:1833-44.
27. Wang M, Lamberth K, Harndahl M et al. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 2007; 25:2823-31.
28. Wang M, Larsen MV, Nielsen M et al. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses. PLoS ONE 2010; 5:e10533.
29. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, Lund O, Nielsen M. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 2005; 35:2295-303.
30. Harndahl M, Justesen S, Lamberth K, Roder G, Nielsen M, Buus S. Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays. J Biomol Screen 2009; 14:173-80.
31. Ostergaard PL, Nissen MH, Hansen NJ et al. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur J Immunol 2001; 31:2986-96.
32. Justesen S, Harndahl M, Lamberth K, Nielsen LL, Buus S. Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res 2009; 5:2.
33. Doolan DL, Southwood S, Freilich DA et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA 2003; 100:9952-7.
34. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-44.
35. Domenech P, Barry CE III, Cole ST. Mycobacterium tuberculosis in the post-genomic age. Curr Opin Microbiol 2001; 4:28-34.
36. Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol 1994; 152:3904-12.
37. Sette A, Vitiello A, Reherman B et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994; 153:5586-92.
38. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:51-88.
39. + T cell responses more than 30years post-vaccinia virus vaccination. Clin Exp Immunol 2009; 155:441-6.
40. Banu S, Honore N, Saint-Joanis B, Philpott D, Prevost MC, Cole ST. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 2002; 44:9-19.
41. Skeiky YA, Ovendale PJ, Jen S et al. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol 2000; 165:7140-9.
42. Okkels LM, Brock I, Follmann F et al. PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun 2003; 71:6116-23.
43. Khan N, Alam K, Nair S, Valluri VL, Murthy KJ, Mukhopadhyay S. Association of strong immune responses to PPE protein Rv1168c with active tuberculosis. Clin Vaccine Immunol 2008; 15:974-80.
44. Dillon DC, Alderson MR, Day CH et al. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun 1999; 67:2941-50.
45. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992; 358:764-8.
46. Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991; 353:622-7.
47. York IA, Goldberg AL, Mo XY, Rock KL. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 1999; 172:49-66.
48. Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, Justesen S, Buus S, Lund O. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 2008; 4:e1000107.
49. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434:88-93.
50. + T lymphocytes. Nature 2003; 421:852-6.
51. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:337-9.
52. + T cells after acute infection. Nat Immunol 2004; 5:927-33.
53. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:339-42.
54. Lewinsohn DA, Winata E, Swarbrick GM et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 2007; 3:1240-9.
55. + T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol 1998; 160:2374-9.